Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Cancers|January 14, 2021
The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular CarcinomaPhilippe MerleViruses|October 14, 2011
Molecular mechanisms underlying hepatocellular carcinomaPhilippe Merle, Christian TrepoLiver Cancer|December 5, 2019
Systemic Treatment Options in Hepatocellular CarcinomaLorenza Rimassa, Tiziana Pressiani, Philippe MerleSeminars in Cancer Biology|September 21, 2010
Gene signatures in hepatocellular carcinoma (HCC)Ourania M Andrisani, Leo Studach, Philippe MerleCancer Treatment Reviews|June 14, 2019
Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinomaLorenza Rimassa, Romano Danesi, Tiziana Pressiani, et al.Bulletin Du Cancer|September 21, 2020
[Management of immune checkpoint inhibitors-induced liver toxicity in cancer]Fanny Lebossé, Brigitte Bancel, Massimo Levrero, et al.Clinics and Research in Hepatology and Gastroenterology|August 20, 2013
Update on hepatocellular carcinoma breakthroughs: poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategyClément Guillot, Janet Hall, Zdenko Herceg, et al.Hepatobiliary Surgery and Nutrition|April 26, 2021
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?Ti Zhang, Philippe Merle, Huaqi Wang, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 26, 2022
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?Gael S Roth, François Villeret, Thomas Decaens, et al.Journal of Experimental & Clinical Cancer Research : CR|September 12, 2013
Cause-specific telomere factors deregulation in hepatocellular carcinomaManale El Idrissi, Valérie Hervieu, Philippe Merle, et al.Pageof 14